Future of Health Grant Level 2 support · Healthtech

Prevision Medicine joins Future of Health Grant’s Spring 2026 cohort

The Zurich company was selected for Level 2 support for its functional oncology testing business.

Prevision Medicine was selected for Level 2 of the Future of Health Grant in the Spring 2026 intake announced on March 5.

The programme provides non-dilutive support, coaching and access to healthcare partners. Prevision tests living patient cancer cells against drugs and combinations, supplying functional response data to the treating oncologist.

Funding history

Future of Health Grant Level 2 support · This roundUndisclosed

Sources

  1. Future of Health Grant historical programme announcementfuture-of-health.org · Mar 5, 2026